These GLP-1 receptor agonist weight loss injections, originally developed for managing type 2 diabetes, not only promote significant weight loss but may also help with countless obesity-related health risks including pre-diabetes, heart disease, sleep apnea, and more
If stopping medication is preferred or necessary, work closely with your healthcare provider to: Taper gradually (do not stop suddenly, especially Qsymia) Increase physical activity to at least 60 minutes per day Follow a structured eating plan emphasizing whole, minimally processed foods Monitor weight regularly (weekly self-weighing) Return promptly if weight begins to increase significantly Consider intermittent or cyclical use
Hormonal Changes : Weight loss can affect hormones like leptin and ghrelin, increasing hunger and reducing metabolic rate
Track burping for the remainder of week two and compare to week one
Early worsening of diabetic retinopathy (EWDR) was first reported in individuals with type 1 diabetes receiving intensive treatment with insulin [2, 3]
Does Medicaid cover semaglutide for weight loss